News
Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top ...
Shipments of vapes from China to the U.S. ground to a near halt in May from a year ago, official data shows, hit by U.S.
A joint operation conducted by the Food and Drug Administration and Customs and Border Protection resulted in the seizure of ...
3d
Pharmaceutical Technology on MSNZymeworks’ zanidatamab gains approval in China for biliary tract cancerChina’s National Medical Products Administration (NMPA) has conditionally approved Zymeworks’ zanidatamab for biliary tract ...
China's anti-graft watchdog is investigating Bi Jingquan, the former head of the China Food and Drug Administration. | ...
The US Food and Drug Administration (FDA) has approved Qamzova, a groundbreaking painkiller created by Delova, a biotech ...
3d
Pharmaceutical Technology on MSNCirCode Biomed gains clearance from FDA for RNA drug HM2002HM2002 offers advantages due to its composition of circular RNAs, which provide improved stability and low immunogenicity.
A new study has found a super-sweet chemical in illegal flavored e-cigarettes that may make them more appealing to kids and ...
2d
Vietnam Investment Review on MSNXellSmart gains FDA clearance for three iPSC cell therapiesXellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has received ...
SMMT's HARMONi trial shows PFS benefits for ivonescimab in EGFR-mutant NSCLC, but lack of proven overall survival raises ...
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...
A joint operation conducted by the Food and Drug Administration and U.S. Customs and Border Protection resulted in the seizure of nearly two million illegal e-cigarettes, most of which came ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results